TCP-MP-CA
TCP-MP-CA (compound 11a) is an inhibitor of LSD1 demethylation enzymatic via binding to LSD1/CoREST complex. TCP-MP-CA exhibits an inhibitory effect on osteoclastogenesis, with an IC50 value of 0.14 µM[1].
Product Specifications
UNSPSC
12352005
Target
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tcp-mp-ca.html
Smiles
OC1=C(O)C=C(/C=C/C(N2CCC(CN[C@H]3[C@H](C4=CC=CC=C4)C3)CC2)=O)C=C1.Cl
Molecular Formula
C24H29ClN2O3
Molecular Weight
428.95
References & Citations
[1]Zhihao Chen, et al. Discovery of TCP- (MP) -caffeic acid analogs as a new class of agents for treatment of osteoclastic bone loss. Bioorg Chem. 2024 Sep:150:107603.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
